Panacea Biotec Limited

NSE:PANACEABIO.NS

347.9 (INR) • At close November 1, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Omzet 5,591.74,599.56,592.236,176.495,371.864,523.365,860.35,4486,530.86,871.95,153.76,084.97,100.911,437.89,001.4987,881.7198,413.4358,423.5435,419.0153,279.273
Kosten van de omzet 4,1642,526.63,000.072,285.331,745.742,027.092,103.641,750.32,158.12,891.32,1402,634.14,066.65,319.5-501.408-452.622-4.589123.48412.956-346.951
Brutowinst 1,427.72,072.93,592.163,891.163,626.122,496.273,756.663,697.74,372.73,980.63,013.73,450.83,034.36,118.39,502.9078,334.3428,418.0248,300.0595,406.0593,626.224
Brutowinstmarge 0.2550.4510.5450.630.6750.5520.6410.6790.670.5790.5850.5670.4270.5351.0561.0571.0010.9850.9981.106
Onderzoek- en ontwikkelingskosten 175.9328.2358.03390.17107.08255.83144.6425.23452.883.286.2840753.1753.063669.944541.856505.012280.926140.562
Algemene en administratieve kosten 1,529.63158.4276.71274.67202.59239.76229.9189263.81,412.1298.5420.7884.700004,287.1173,194.8652,265.726
Verkoop- en marketingkosten 113.04231.4480.84511.81428.08312.65369.83276.1350.8256460.9488.7576.5611.2474.656458.23492.3342.398251.151203.908
Verkoop-, algemene en administratieve kosten 1,995.4389.8757.55786.48630.67552.41599.73465.1614.61,668.12,661.42,739.11,461.2611.2474.656458.23492.34,629.5143,446.0172,469.634
Overige kosten 258516.633.9720.168.6720.855.1166.984.224.94,467.75,120.3-2.92,688.66,719.0577,722.8625,354.637873.873551.524478.945
Bedrijfskosten 1,995.43,443.74,123.593,523.963,205.523,543.983,374.73,1923,806.93,9924,467.75,120.34,051.84,052.97,946.7758,851.0376,388.7936,008.3994,278.4673,089.14
Bedrijfsresultaat -567.7-1,027.39-484.18427.33429.26-1,105.51381.96-567.2-189.3-994.1-1,109.6-2,530.6-1,017.52,063.71,556.132-516.6952,029.2312,291.661,127.592537.084
Bedrijfsresultaat ratio -0.102-0.223-0.0730.0690.08-0.2440.065-0.104-0.029-0.145-0.215-0.416-0.1430.180.173-0.0660.2410.2720.2080.164
Totaal overige inkomsten en kosten netto 582.51,155.4414,977.74-1,869.79-2,141.461,591.66-1,043.35-1,072.9-755.1-982.7344.4-861.1-1,581-521.7-428.424-349.969-152.373-173.102-140.75-134.623
Inkomen voor belasting 14.812814,488.09-1,442.46-1,712.2486.15-661.39-567.2-189.3-994.1-1,109.6-2,530.6-2,598.51,543.71,127.708-866.6641,876.8582,118.557986.842402.461
Inkomen voor belasting ratio 0.0030.0282.198-0.234-0.3190.107-0.113-0.104-0.029-0.145-0.215-0.416-0.3660.1350.125-0.110.2230.2520.1820.123
Belastingkosten 29.8465.53,709.0519.57166.477.0798.5837.119.230.816.8-187.6-541.9218.9416.679206.739587.041642.108394.376129.544
Nettowinst -11.7-337.510,783.15-1,476.96-1,942.67377.27-759.97-644.6-182.9-1,065.1-1,121.3-2,342.8-2,056.61,324.8724.12-659.9251,289.8171,476.449592.467272.916
Nettowinstmarge -0.002-0.0731.636-0.239-0.3620.083-0.13-0.118-0.028-0.155-0.218-0.385-0.290.1160.08-0.0840.1530.1750.1090.083
WPA (Winst Per Aandeel) -0.19-5.51176.05-24.11-31.726.16-12.41-10.52-2.99-17.39-18.31-38.25-33.5822.9812.24-9.8919.5123.849.573.91
Verwaterde WPA -0.19-5.51176.05-24.11-31.726.16-12.41-10.52-2.99-17.39-18.31-38.25-33.5822.9811.46-9.2618.2521.859.363.91
EBITDA -200.6-463-31.14868.22904.74-825.08887.461,1161,294.5648-2,513.9-806.1-246.92,820.72,217.102247.2712,496.8092,670.4741,319.258692.524
EBITDA ratio -0.036-0.101-0.0050.1410.168-0.1820.1510.2050.1980.094-0.488-0.132-0.0350.2470.2460.0310.2970.3170.2430.211